Advertisement

Topics

Pharmacyclics, Inc. Company Profile

09:50 EDT 18th June 2018 | BioPortfolio

Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune-mediated diseases and cancer. Our mission and goal are worth repeating: to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life, and resolve serious unmet medical healthcare needs. To identify promising product candidates based on exceptional scientific development expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate. We exist to make a difference for the better and these are important times to do just that.


News Articles [5 Associated News Articles listed on BioPortfolio]

Oncternal, Pharmacyclics Enter Supply Agreement

Pharmacyclics to supply ibrutinib, a small molecule inhibitor of Bruton's tyrosine kinase (BTK), for a Phase 1b/2 trial

STAT Plus: AbbVie and J&J reverse course on a price hike in face of criticism

Pharmacyclics quietly released a statement on its website last Friday morning saying “we have received feedback” and will not yank the older pill.

ZEAL Displays Vigor, MDWD Getting Healed, VERU Up 80% YTD

CASI Pharmaceuticals Inc. (CASI) gained 21.81% on Tuesday, following a $50 million private placement. The financing was led by ETP Global Fund LP, IDG-Accel China Growth Fund III, and Robert W. Duggan...

CASI commences $50mm PIPE; gets $25.3mm to start

Oncology firm CASI Pharmaceuticals Inc. entered into definitive agreements with investors (including ETP Global Fund LP, IDG-Accel China Growth Fund III, and Robert W. Duggan, former chairman and CEO ...

Pharmacyclics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19022018] Prices from USD $250

SummaryPharmacyclics Inc Pharmacyclics, a whollyowned subsidiary of AbbVie, discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company'...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Pharmacyclics, Inc.

Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune-mediated diseases and cancer. Our mi...

Bristol-Myers Squibb Company and Pharmacyclics, Inc. and Janssen Research & Development, LLC

Pharmacyclics Incorporated

Pharmacyclics, Inc. is a pharmaceutical company developing energy-potentiating drugs to improve radiation therapy andchemotherapy of cancer, and to enable or improve the photodynamic therapy of certai...

More Information about "Pharmacyclics, Inc." on BioPortfolio

We have published hundreds of Pharmacyclics, Inc. news stories on BioPortfolio along with dozens of Pharmacyclics, Inc. Clinical Trials and PubMed Articles about Pharmacyclics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmacyclics, Inc. Companies in our database. You can also find out about relevant Pharmacyclics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record